CFD Order Sample Clauses

CFD Order. Execution 1.1 Orders can be placed, executed and (if allowed) changed or removed within the trading hours for each CFD appearing on the Company’s Website, as amended by the Company from time to time and if they are not executed they shall remain effective through the next trading session (as applicable). All open spot positions will be rolled over to the next Business Day at the close of business in the relevant Underlying Market, subject to the Company’s rights to close the open spot position. Any open forward positions will be rolled over at the expiry of the relevant period into the next relevant period subject to the Company’s rights to close the open forward position. 1.2 The Company shall not be obliged to arrange for the execution of the Client’s Orders in respect of any CFD out of normal trading hours which appear on the Company’s Website. 1.3 Orders shall be valid in accordance with the type and time of the given Order, as specified by the Client. If the time of validity of the order is not specified, it shall be valid for an indefinite period. However, the Company may delete one or all Pending Orders if the Client Account Equity reaches zero and/or for any other justifiable reason. 1.4 Orders cannot be changed or removed if a trade confirmation is sent or they are executed or being executed or the market is closed. The Client has no right to change or remove Sell Limit and Take Profit if the price has reached the level of the Order Execution. 1.5 The Client may change the expiration date of Pending Orders.
Sample 1Sample 2Sample 3See All (24)
AutoNDA by SimpleDocs
CFD Order. Execution 1.1 Orders can be placed, executed and (if allowed) changed or removed within the Trading Hours for each CFD appearing on the Company’s Website, as amended by the Company from time to time and if they are not executed they shall remain effective through the next trading session (as applicable). All open spot positions will be rolled over to the next Business Day at the close of business in the relevant Underlying Market, subject to the Company’s rights to close the Open spot Position. Any Open forward 1.2 The Company shall not be obliged to arrange for the execution of the Client’s Orders in respect of any CFD out of normal Trading Hours which appear on the Company’s Website. 1.3 Orders shall be valid in accordance with the type and time of the given Order, as specified by the Client. If the time of validity of the order is not specified, it shall be valid for an indefinite period. However, the Company may delete one or all Pending Orders if the Client Account Equity reaches zero. 1.4 Orders cannot be changed or removed if a trade confirmation is sent or they are executed or being executed, or the market is closed. The Client has no right to change or remove Sell Limit and Take Profit if the price has reached the level of the Order Execution. 1.5 The Client may change the expiration date of pending Orders.
Sample 1Sample 2
CFD Order. Execution 1.1 Orders can be placed, executed and (if allowed) changed or removed within the Trading Hours for each CFD appearing on the Company’s Website, as amended by the Company from time to time and if they are not executed they shall remain effective through the next trading session (as applicable). All open spot positions will be rolled over 1.2 The Company shall not be obliged to arrange for the execution of the Client’s Orders in respect of any CFD out of normal Trading Hours which appear on the Company’s Website. 1.3 Orders shall be valid in accordance with the type and time of the given Order, as specified by the Client. If the time of validity of the order is not specified, it shall be valid for an indefinite period. However, the Company may delete one or all Pending Orders if the Client Account Equity reaches zero. 1.4 Orders cannot be changed or removed if a trade confirmation is sent or they are executed or being executed, or the market is closed. The Client has no right to change or remove Sell Limit and Take Profit if the price has reached the level of the Order Execution. 1.5 The Client may change the expiration date of pending Orders.
Sample 1
CFD Order. Execution 1.1 Orders can be placed, executed and (if allowed) changed or removed within the Trading Hours for each CFD appearing on the Company’s Website, as 1. การดาํ เนินการคาํ สั่งซ้ือขาย CFD 1.1 ลูกคา้ สามารถเปิ ดและดาํ เนินการคาํ สั่งซ้ือขาย และ เปล่ียนแปลงหรือลบคาํ สั่งซ้ือขาย (หากได้รั บอนุ ญาต) ภายใน ชั่วโมงการซ้ือขายของแตละ CFD ท่ีปรากฏบนเวบไซตข์ อง บริษั ท ซ่ึงบริษั ทมีการปรั บปรุงแก้ไขเป็นครั ง้ คราว และหากคา amended by the Company from time to time and if สั่งไมไ่ ด้รั บการดาํ เนินการ คาํ สั่งนั น ้ ่ ่ จะยังมีผลจนถึงรอบการ they are not executed they shall remain effective through the next trading session (as applicable). All open spot positions will be rolled over to the next Business Day at the close of business in the relevant Underlying Market, subject to the Company’s rights ซือขายถั ดไป (ตามทีมี) เมือถึงเวลาปิ ดตลาดอ้างอิง สถานะส ปอตทั ง้ หมดท่ีเปิ ดไวจะยกยอดไปในวันทาํ การถั ดไป ทั ง้ น้ บริษั ทมีสทธิปิ ดสถานะสปอตนั นด้วย เม่ือถึงเวลาหมดอายุ สัญญา สถานะฟอร์เวริ ์ดใดๆ ท่ีเปิ ดไวจะยกยอดไปในรอบการ ซ้ือขายถั ดไป ทั ง้ น้ี บริษั ทมีสทธิปิ ดสถานะฟอร์เวริ ์ดนั นด้วย to close the Open spot Position. Any Open forward 1.2 บริษั ทไมมีหน้าที่จัดให้มีการดาํ เนินการคาํ ส่ังซื้อขายของ Positions will be rolled over at the expiry of the relevant period into the next relevant period subject to the Company’s rights to close the open forward ลูกคา้ ใน CFD ใดๆ นอกชว บนเวบไซตข์ องบริษั ท งเวลาซ้ือขายปกติ ซ่ึงปรากฏอยู position. 1.3 คาํ สั่งซ้ือขายจะยังมีผลตามประเภทและเวลาของคาํ สั่งซ้ือ ขายนั น ซึ่งลูกคา้ กาํ หนดไว้ ถ้าไมไ่ ด้ระบุอายุหรือชวงเวลาที่คา
Sample 1
CFD Order. Execution 1.1 Orders can be placed, executed and (if allowed) changed or removed within the Trading Hours for each CFD appearing on the Company’s Website, as amended by the Company from time to time and if they are not executed they shall remain effective through the next trading session (as applicable). All open spot positions will be rolled over to the next Business Day at the close of business in the relevant Underlying Market, subject to the Company’s rights to close the Open spot Position. Any Open forward Positions will be rolled over at the expiry of the relevant period into the next relevant period subject to the Company’s rights to close the open forward position. 1.2 The Company shall not be obliged to arrange for the execution of the Client’s Orders in respect of any CFD out of normal Trading Hours which appear on the Company’s Website. 1.3 Orders shall be valid in accordance with the type and time of the given Order, as specified by the 1.4 Orders cannot be changed or removed if a trade confirmation is sent or they are executed or being executed or the market is closed. The Client has no right to change or remove Sell Limit and Take Profit if the price has reached the level of the Order Execution. 1.5 The Client may change the expiration date of pending Orders.
Sample 1
CFD Order. Execution
Sample 1

Related to CFD Order

  • Field Order A written order issued by Engineer which requires minor changes in the Work but does not change the Construction Contract Price or the Construction Contract Times.

  • Field Orders The documents listed in Paragraph 9.01.A are attached to this Agreement (except as expressly noted otherwise above).

  • Preliminary Approval Order “Preliminary Approval Order” means the order of the Court preliminarily approving this Settlement Agreement.

  • Final Order This Consent Agreement and Final Order, as agreed to by the parties, shall become effective immediately upon filing with the Regional Hearing Clerk. This Final Order concludes this proceeding pursuant to 40 C.F.R. §§ 22.18 and 22.31. IT IS SO ORDERED. XXX XXXXX Digitally signed by XXX XXXXX Date: 2022.04.14 09:47:24 -05'00' Xxx X. Xxxxx Regional Judicial Officer United States Environmental Protection Agency Region 5 In the Matter of: Ag Partners Cooperative Docket Number: FIFRA-05-2022-0006

  • Layoff Order Seasonal employees shall be seasonally laid off in inverse order of Classification Seniority (State Seniority for Units 4 and 6) within the employment condition, seniority unit and principal place of employment of the affected position(s) unless waived by mutual agreement between the employee and the Appointing Authority.

  • Sale Order The Sale Order shall, among other things, (a) approve, pursuant to sections 105, 363 and 365 of the Bankruptcy Code, (i) the execution, delivery and performance by Sellers of this Agreement, (ii) the sale of the Acquired Assets to Buyer on the terms set forth herein and free and clear of all Encumbrances (other than Permitted Encumbrances), and (iii) the performance by Sellers of their obligations under this Agreement, (b) authorize and empower Sellers to assume and assign to Buyer the Transferred Contracts, (c) find that Buyer is a “good faith” purchaser within the meaning of section 363(m) of the Bankruptcy Code, find that Buyer is not a successor to any Seller, and grant Buyer the protections of section 363(m) of the Bankruptcy Code, (d) find that Buyer shall have no Liability or responsibility for any Liability or other obligation of any Seller arising under or related to the Acquired Assets other than as expressly set forth in this Agreement, including successor or vicarious Liabilities of any kind or character, including any theory of antitrust, environmental, successor, or transferee Liability, labor law, de facto merger, or substantial continuity, (e) find that Buyer has provided adequate assurance (as that term is used in section 365 of the Bankruptcy Code) of future performance in connection with the assumption of the Transferred Contracts, (f) find that Buyer shall have no Liability for any Excluded Liability, (g) find that the consideration provided by Buyer pursuant to this Agreement constitutes reasonably equivalent value and fair consideration for the Acquired Assets, (h) find that Buyer and Sellers did not engage in any conduct which would allow this Agreement to be set aside pursuant to section 363(n) of the Bankruptcy Code and (i) order that, notwithstanding the provisions of the Federal Rules of Bankruptcy Procedures 6004(h) and 6006(d), the Sale Order is not stayed and is effective immediately upon entry. Buyer agrees that it will promptly take such actions as are reasonably requested by any Seller to assist in obtaining Bankruptcy Court approval of the Sale Order, including furnishing affidavits or other documents or information for filing with the Bankruptcy Court for purposes, among others, of (A) demonstrating that Buyer is a “good faith” purchaser under section 363(m) of the Bankruptcy Code and (B) establishing adequate assurance of future performance within the meaning of section 365 of the Bankruptcy Code.

  • MSAA Indicator Technical Specification Document This Agreement shall be interpreted with reference to the MSAA Indicator Technical Specifications document.

  • Scope and Order Placement These terms may be used by Customer either for a single Order or as a framework for multiple Orders. In addition, these terms may be used on a global basis by the parties’ “Affiliates”, meaning any entity controlled by, controlling, or under common control with a party. The parties can confirm their agreement to these terms either by signature where indicated at the end or by referencing these terms on Orders. Affiliates participate under these terms by placing orders which specify product or service delivery in the same country as the HP Affiliate accepting the Order, referencing these terms, and specifying any additional terms or amendments to reflect local law or business practices.

  • Confirmation Order The Bankruptcy Court shall have entered the Confirmation Order, and such Order shall be a Final Order.

  • FDA As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (“FDA”) under the Federal Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (“FDCA”) that is manufactured, packaged, labeled, tested, distributed, sold, and/or marketed by the Company or any of its Subsidiaries (each such product, a “Pharmaceutical Product”), such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed by the Company in compliance with all applicable requirements under FDCA and similar laws, rules and regulations relating to registration, investigational use, premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices, good clinical practices, product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure to be in compliance would not have a Material Adverse Effect. There is no pending, completed or, to the Company's knowledge, threatened, action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation) against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any notice, warning letter or other communication from the FDA or any other governmental entity, which (i) contests the premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii) imposes a clinical hold on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the Company or any of its Subsidiaries, (v) enters or proposes to enter into a consent decree of permanent injunction with the Company or any of its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company or any of its Subsidiaries, and which, either individually or in the aggregate, would have a Material Adverse Effect. The properties, business and operations of the Company have been and are being conducted in all material respects in accordance with all applicable laws, rules and regulations of the FDA. The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in the United States of any product proposed to be developed, produced or marketed by the Company nor has the FDA expressed any concern as to approving or clearing for marketing any product being developed or proposed to be developed by the Company.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!